Patients Coming Off Anti-Obesity Jabs Regain Pounds Four Times Faster Than Those on Conventional Diets

A recent study suggests that people who stop using new GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end conventional diet and exercise programs.

Published data in a prominent health publication points out that while obese individuals often shed a large proportion of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month after stopping.

"People buying these medications must be informed of the danger of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.

Such speed of recovery suggests a reversion to pre-treatment mass within about one and a half years.

Comparing Therapies

The analysis, which looked at dozens of studies involving thousands of participants, compared the outcomes of these new drugs with older methods.

Scientists emphasize that people who shed pounds through dieting usually see a more gradual creep back—perhaps 100 grams monthly—after stopping.

Explaining the Rapid Rebound

Doctors propose the way of the injections accounts for the accelerated rebound.

GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement leads to hunger is unsuppressed, making binge eating much more probable."

An Ongoing Condition?

The NHS suggest the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.

Professionals argue that, due to the significant potential of relapse, the therapy should be considered long-term.

This perspective is supported by drug manufacturers, who say that the findings "underscore the chronic character of excess weight," similar to managing diseases like high blood pressure.

User Accounts

Users who have stopped the medication describe a powerful resurgence of appetite.

"It was like something flipping and you're instantly ravenous," said an individual.

The struggle is worsened if patients have not adopted permanent lifestyle or habit changes during therapy.

Widespread Adoption

Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.

• Use is more common among women than men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than the NHS.

In conclusion, clinicians emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic solution and lasting health benefits hinges on integrated behavioural support.